WealthPLAN Partners LLC Sells 24 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

WealthPLAN Partners LLC lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 499 shares of the healthcare conglomerate’s stock after selling 24 shares during the period. WealthPLAN Partners LLC’s holdings in UnitedHealth Group were worth $292,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of UNH. Delta Financial Group Inc. grew its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after purchasing an additional 17 shares during the last quarter. Signature Resources Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC increased its stake in shares of UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after buying an additional 18 shares during the period. GoalVest Advisory LLC increased its position in UnitedHealth Group by 0.6% during the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC increased its position in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on UNH. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Bank of America cut their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. TD Cowen increased their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price objective for the company from $481.00 to $647.00 in a report on Wednesday, July 17th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Down 1.6 %

UNH stock opened at $615.01 on Wednesday. The company has a market capitalization of $565.98 billion, a price-to-earnings ratio of 40.07, a PEG ratio of 1.84 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a fifty day moving average of $582.63 and a 200-day moving average of $546.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the firm earned $6.56 EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.